As part of the NHS ADHD/ASD referral initiative, you have the option to choose your preferred provider for diagnosis and treatment. This means that instead of being restricted to one service, you can select a provider that best suits your needs from a list of approved services.
You can either be referred to NHS Neurodevelpmental Services, current waiting times in Coventry and Warwickshire are around 3-5 years.
Or you can use the Right to Choose Initiative which is detailed below.
For more information on Coventry and Warwickshire's services and FAQ's please visit https://www.happyhealthylives.uk/services-programmes/adhd-and-autism/
Right to Choose:
To support you in making your decision, we have provided the full list of providers and more information on the Right to Choose on their website
here: https://adhduk.co.uk/nhs-area/nhs-coventry-and-warwickshire-icb/
What You Need to Do:
- Visit the Right to Choose Page: Please follow the link above to view a range of service providers offering ASD/ADHD assessments and treatments.
- Choose Your Provider: Review the providers and select one that best suits your preferences. Ensure that your choice can both assess for ASD/ADHD and prescribe medication (if this is your preferred option).
- Complete 2 Forms: Once you have made your choice, you will need to complete two forms that apply to the condition you're referring for.
ADHD Self Report Scale ADHD Impact Assessment Autism Self Report Scale Autism Impact Assessment
- Submit Your Form to Brookside Surgery: After completing these forms, please send it to us through the ‘Contact Us’ portal on our website and state the provider you ave chosen so we can initiate your referral.
As a practice, we are committed to ensuring you receive the best possible care and support, and we appreciate you taking the time to choose the provider that works best for you.
In order to take over prescribing of any ASD/ADHD medication, Brookside Surgery enters a Shared Care Prescribing agreement with the designated provider. As part of this, every patient will need a yearly review by a specialist for us to continue prescribing. It is important to be aware that this may need to be undertaken privately, however, you can clarify this up-front with your chosen provider.
Providers responsibility:
- Discuss the benefits and side effects of treatment with the patient.
- Initiate and stabilise treatment with medication as part of a care package
- Notify the patient of any off-label unlicensed use, and gain appropriate informed consent
- Ask the GP whether he or she is willing to participate in shared care by emailing the shared care request letter (continue to prescribe until GP has agreed to take over prescribing).
- Communicate to the GP re-established regimen; follow up arrangements and when to refer back.
- Communicate promptly with the GP when treatment is changed.
- Monitor treatment as stated overleaf.
- Notify GP of review date (at least annually), and give advice on stopping treatment. NB Drug holidays may not be possible, and on-going daily treatment may be required.
- Have a mechanism in place to receive referral of a patient from the GP in the event of rare or severe side-effects, significant deterioration in mental health, suicidal ideation, or cardiovascular problems.
- Ensure that clear backup arrangements exist for GPs to obtain advice and support.
Report adverse events to the MHRA on a Yellow Card www.mhra.gov.uk/yellowcard and to the GP and appropriate Medicines Optimisation team (If in CWPT, report via the Clinical Governance Pharmacist – see Medicines Policy and associated guidance MMG20)
If you have any questions or require further assistance, please do not hesitate to contact our reception team, who will be happy to support you through the process.